Potential role for nitazoxanide in treating SARS-CoV-2 infection

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

(2020) James M. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness

(2019) Ana E Gamiño-Arroyo et al.   CLINICAL INFECTIOUS DISEASES

Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus

(2016) Jean-François Rossignol   Journal of Infection and Public Health

Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome

(2015) Jose L. Nieto-Torres et al.   VIROLOGY

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

(2014) Jason Haffizulla et al.   LANCET INFECTIOUS DISEASES

Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca2+ stores

(2014) Omodele Ashiru et al.   VIROLOGY

Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice

(2012) Seong Keun Hong et al.   INTERNATIONAL IMMUNOPHARMACOLOGY